Harper, of course, denies the remarks and says the report is fabricated. You can see the nutcase cluster here. You can read the saga here. You can't read the article in the Sunday Express, because it's been removed pending a Press Council investigation.
From Goldacre:
I will explain Harper's position in her own words. They are unambiguous: "I did not say that Cervarix was as deadly as cervical cancer. I did not say that Cervarix could be riskier or more deadly than cervical cancer. I did not say that Cervarix was controversial, I stated that Cervarix is not a 'controversial drug'. I did not 'hit out' ? I was contacted by the press for facts. And this was not an exclusive interview."
Harper did not "develop Cervarix" but she did work on some important trials of Gardasil and also Cervarix. "Gardasil is not a 'sister vaccine' as the Express said, it is a different compound. I do not know of the side effects of Cervarix as it is not available in the US."
She did not say that Cervarix was being overmarketed. "I did say that Merck was egregiously overmarketing Gardasil in the US ? but Gardasil and Cervarix are not the same vaccines."
Here is the tragedy. In a clear example of how academics are often independent-minded about the interventions they work on, Harper is a critic of Gardasil, or more specifically of how it is marketed. Briefly, her view is that we do not yet know how long the protection from these vaccines will last, and this will affect the cost-benefit decisions.
She is concerned that aggressive advertising aimed directly at the public ? which is not permitted in Europe ? may lead people to falsely believe they are invincible to HPV (human papilloma viruses, some types of which can increase the risk of developing cervical cancer), and so neglect other precautions. She also suspects from modelling data that for the specific and restricted group ofwomen who are punctilious about attending every single one of their cervical cancer screening appointments, vaccination may have little impact on their risk of death from cancer; but even they will benefit from the reduction in reproductive problems caused by treating pre-cancerous changes in cervical cells.
The article has now gone from the Express website, and Harper has complained to the Press Complaints Commission. "I fully support the HPV vaccines," she says. "I believe that in general they are safe in most women. I told the Express all of this."
Her criticisms of aspects of cervical cancer vaccination are nuanced and valuable, but do not fit the black and white hysteria of the British media. A public discussion about the merits of different treatment options would be nice. Sadly, this is not currently possible.